Compare REGN & CTAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REGN | CTAS |
|---|---|---|
| Founded | 1988 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8B | 80.3B |
| IPO Year | 1995 | 1994 |
| Metric | REGN | CTAS |
|---|---|---|
| Price | $790.24 | $200.29 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 25 | 10 |
| Target Price | ★ $830.16 | $215.80 |
| AVG Volume (30 Days) | 526.4K | ★ 1.8M |
| Earning Date | 04-29-2026 | 03-25-2026 |
| Dividend Yield | 0.55% | ★ 1.03% |
| EPS Growth | 8.19 | ★ 11.59 |
| EPS | ★ 18.95 | 4.91 |
| Revenue | $5,872,227,000.00 | ★ $6,892,303,000.00 |
| Revenue This Year | $12.45 | $10.75 |
| Revenue Next Year | $10.13 | $7.52 |
| P/E Ratio | $42.01 | ★ $40.26 |
| Revenue Growth | ★ 20.82 | N/A |
| 52 Week Low | $541.00 | $161.16 |
| 52 Week High | $859.34 | $219.17 |
| Indicator | REGN | CTAS |
|---|---|---|
| Relative Strength Index (RSI) | 48.83 | 51.61 |
| Support Level | $758.85 | $197.73 |
| Resistance Level | $818.06 | $206.72 |
| Average True Range (ATR) | 17.66 | 3.92 |
| MACD | -3.06 | -0.27 |
| Stochastic Oscillator | 40.15 | 67.85 |
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.
Cintas has roots dating back to 1929, when the Farmer family cleaned and resold dirty rags to manufacturing plants in Ohio. The firm has expanded its business organically and through acquisitions, and today Cintas acts as a one-stop outsourcing partner for businesses. Cintas will design, manufacture, collect, and clean every employee uniform for a small weekly sum, taking on the upfront capital expense itself. At the same stop, Cintas can also replace soiled or depleted mats, mops, trash liners, towels, first aid supplies, fire extinguishers, and cleaning products. Businesses value an outsourcing partner like Cintas as it simplifies operations and leaves noncore tasks with high regulatory standards in the hands of professionals.